Biotechgate, HEALTH MADE IN GERMANY and Germany Trade & Invest (GTAI) to map German Life Science Industry

Zurich/Berlin, January 2018; Venture Valuation entered into a partnership with HEALTH MADE IN GERMANY, the export promotion program for the German healthcare industry initiated by the German Federal Ministry for Economic Affairs and Energy. HEALTH MADE IN GERMANY is implemented by Germany Trade & Invest (GTAI), the country’s economic development agency.  It is Venture Valuation’s … Continue reading Biotechgate, HEALTH MADE IN GERMANY and Germany Trade & Invest (GTAI) to map German Life Science Industry

Read more

J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate

14 January 2019. Last week saw the annual J.P. Morgan Healthcare Conference held in San Francisco. Venture Valuation and Biotechgate was represented by CEO, Patrik Frei and Senior Business Development Executive Ray Carroll providing their insights into the industry announcements. It was again a busy week in San Francisco kicking off the Bio year 2019 … Continue reading J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate

Read more

The Mandarin translation of Site Selection Report for Life Sciences Companies in Europe 2018

Site Selection Report for Life Sciences Companies in Europe 2018 is now available in Mandarin and can be downloaded free by clicking at the link below: 生命科学企业在欧洲的选址(2018年版 The report, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include … Continue reading The Mandarin translation of Site Selection Report for Life Sciences Companies in Europe 2018

Read more

Site Selection Report for Life Sciences Companies in Europe 2018

The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five … Continue reading Site Selection Report for Life Sciences Companies in Europe 2018

Read more

Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni

On 7th of June 2017, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School. The online event was a part of Healthcare Roundtable, a series of interactive presentations by industry leaders organised by HBS Healthcare Alumni Association. Dr. Frei talked about the significance … Continue reading Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni

Read more

What is the value of a deal?

Venture Valuations Dr. Aitana Peire and Dr. Patrik Frei have published an article “What is the value of a deal?” in Nature Publishing Groups’ biopharmadealmakers.nature.com. The article is available online as well as in the biopharmadealmakers supplement June 2016 edition of nature biotechnology and Nature Reviews Drug Discovery. The pharmaceutical and biotechnology industries see over … Continue reading What is the value of a deal?

Read more